Company intelligence / Profile preview

OncoDNA

Gosselies, Belgium

Ownership: Private
Employees: ~100
Development stage: Other

Overview

OncoDNA has commercialized several precision oncology diagnostic and genomic platforms widely used in clinical practice for tumor tissue and liquid biopsy profiling, integrating next-generation sequencing, bioinformatics, and AI-driven clinical support tools. The company is not a therapeutic developer but provides key enablement for personalized medicine decisions and pharmaceutical research, with adoption at major cancer centers[1][2][3][4][5].

Therapeutic areas: Oncology
Modalities: Diagnostic testNGS-based diagnosticsBioinformatics
Industry: Molecular Diagnostics

Partnerships

Strasbourg University HospitalOncology Center of BydgoszczMultiple global oncology centers (Moncodaneum consortium)SOLTI

Beyond the preview

Go deeper on OncoDNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoDNA.

Explore the full profile